Insulin Infusion Mode Switching With User-Configurable Alerts

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing insulin infusion systems lack user-configurable notifications and fail to adapt to individual user preferences, potentially disrupting sleep by continuously operating in closed-loop mode without considering user-specific alert configurations.

Innovation Solution

Implementing a user-configurable notification system that allows users to customize alert settings, including notification type, frequency, and response mechanisms, and adapts insulin delivery mode based on user input, such as updated blood glucose measurements, to ensure safe and personalized operation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If continuous closed-loop insulin infusion control is implemented, then blood glucose regulation is improved, but user sleep is disrupted due to lack of customizable notifications

Engineering Contradiction:
Improveblood glucose regulationVSAvoidsleep disruption
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system dynamically transitions between closed-loop and open-loop operational modes based on user interaction. When the user responds to a notification by providing manual blood glucose data, the system switches from autonomous closed-loop control to open-loop mode, allowing the user to resume control and avoid sleep disruption while maintaining glucose regulation capability.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system implements a feedback mechanism where notifications are sent to the user when sensor data is unavailable or out of range. The user's response to these notifications provides feedback that triggers mode switching, enabling the system to adapt its control strategy based on user needs and preferences.

Inventive Principle:
Principle #23Feedback

2Measurement precision

If closed-loop mode operates autonomously without user input, then glucose control precision is improved, but user preference adaptation is reduced

Engineering Contradiction:
Improveglucose control precisionVSAvoiduser preference adaptation
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The system dynamically adjusts its operational mode based on user responses. It transitions from autonomous closed-loop control to user-controlled open-loop mode when users provide manual measurements, allowing the system to adapt to individual user preferences while maintaining precise glucose control capability when needed.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system changes its operational parameters by switching between closed-loop and open-loop modes. This parameter change allows the system to balance autonomous precision control with user preference adaptation, enabling users to choose their level of involvement in the glucose management process.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If sensor data monitoring is continuous, then glucose level accuracy is improved, but system complexity increases due to multiple operational modes

Engineering Contradiction:
Improveglucose level accuracyVSAvoidoperational modes
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments its operational logic into distinct modes (closed-loop and open-loop) with clear transition criteria. This segmentation simplifies the overall system architecture by creating well-defined operational states and transition rules, making the complexity manageable while maintaining continuous monitoring capability for accurate glucose level measurement.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20260069780A1User-configurable closed-loop notifications and infusion systems incorporating same
Publication Date: 2026.03.12 MEDTRONIC MINIMED INC
  • US20260069780A1 patent drawing
  • US20260069780A1 patent drawing
  • US20260069780A1 patent drawing

AI summary

Techniques disclosed herein related to controlling insulin delivery. In some embodiments, the techniques may involve delivering insulin via an insulin infusion device according to a closed-loop mode of delivery. The techniques may further involve determining, at a first time point, insulin delivery is to be switched from the closed-loop mode of delivery to a second mode of delivery. The techniques may further involve switching operation of the insulin infusion device to the second mode of delivery such that insulin is delivered via the insulin infusion device according to the second mode of delivery.